Free Trial Information
BioCentury | Sep 8, 2014
Product Development

Betting big on hearts

...biomarker related to left ventricular ejection fraction. Matchaba said Novartis' acquisition of point-of-care diagnostic company Vivacta Ltd....
Read More
BioCentury | Apr 28, 2014
Strategy

Bigger is better

...Genoptix Inc. for $470 million in 2011. In 2012, Novartis acquired drug monitoring Dx company Vivacta Ltd....
Read More
BioCentury | Dec 24, 2012
Company News

Vivacta, Novartis deal

...Novartis acquired diagnostic company Vivacta for $90 million. Vivacta could not be reached for comment while...
...not be reached for comment while Novartis said the deal provides it with access to Vivacta's...
...monitoring. The pharma will initially focus on transplant patients taking the immunosuppressant indications of everolimus. Vivacta Ltd....
Read More
BioCentury | Feb 27, 2012
Company News

Atlas Genetics board of directors update

...Genetics Ltd. , Bristol, U.K. Business: Diagnostic Appointed: Neil Butler as chairman, formerly CEO of Vivacta Ltd....
Read More
BioCentury | Nov 15, 2010
Financial News

Vivacta completes venture financing

Vivacta Ltd. , Sittingbourne, U.K. Business: Diagnostic Date completed: 11/10/10 Type: Venture financing Raised: £4 million ($6.4 million) Investors: HBM BioVentures; IDInvest Partners; Spark Ventures; Viking WIR Staff Diagnostic...
Read More
BioCentury | Aug 30, 2010
Company News

Vivacta management update

Vivacta Ltd. , Sittingbourne, U.K. Business: Diagnostic Hired: Oliver Boucher as CBO and a director, formerly CBO of Sigmoid Pharma Ltd. Transitioned: Tim Carter to CEO from CSO; he replaces Neil Butler, who also resigned as...
Read More
Items per page:
1 - 6 of 6
BioCentury | Sep 8, 2014
Product Development

Betting big on hearts

...biomarker related to left ventricular ejection fraction. Matchaba said Novartis' acquisition of point-of-care diagnostic company Vivacta Ltd....
Read More
BioCentury | Apr 28, 2014
Strategy

Bigger is better

...Genoptix Inc. for $470 million in 2011. In 2012, Novartis acquired drug monitoring Dx company Vivacta Ltd....
Read More
BioCentury | Dec 24, 2012
Company News

Vivacta, Novartis deal

...Novartis acquired diagnostic company Vivacta for $90 million. Vivacta could not be reached for comment while...
...not be reached for comment while Novartis said the deal provides it with access to Vivacta's...
...monitoring. The pharma will initially focus on transplant patients taking the immunosuppressant indications of everolimus. Vivacta Ltd....
Read More
BioCentury | Feb 27, 2012
Company News

Atlas Genetics board of directors update

...Genetics Ltd. , Bristol, U.K. Business: Diagnostic Appointed: Neil Butler as chairman, formerly CEO of Vivacta Ltd....
Read More
BioCentury | Nov 15, 2010
Financial News

Vivacta completes venture financing

Vivacta Ltd. , Sittingbourne, U.K. Business: Diagnostic Date completed: 11/10/10 Type: Venture financing Raised: £4 million ($6.4 million) Investors: HBM BioVentures; IDInvest Partners; Spark Ventures; Viking WIR Staff Diagnostic...
Read More
BioCentury | Aug 30, 2010
Company News

Vivacta management update

Vivacta Ltd. , Sittingbourne, U.K. Business: Diagnostic Hired: Oliver Boucher as CBO and a director, formerly CBO of Sigmoid Pharma Ltd. Transitioned: Tim Carter to CEO from CSO; he replaces Neil Butler, who also resigned as...
Read More
Items per page:
1 - 6 of 6